Rapidly progressive interstitial lung disease in patients with anti-melanoma differentiation-associated gene 5-positive dermatomyositis: serial changes on HRCT-Reference-Cited by-同舟云学术

Rapidly progressive interstitial lung disease in patients with anti-melanoma differentiation-associated gene 5-positive dermatomyositis: serial changes on HRCT

Published:2022-08-02 Issue:6 Volume:29 Page:961-967
ISSN:1070-3004
Container-title:Emergency Radiology
language:en
Short-container-title:Emerg Radiol

Author:

Kim Minsoo,Harvey Samuel,Danoff Sonye K.,Mecoli Christopher A.,Albayda Jemima,Paik Julie J.,Christopher-Stine Lisa,Illei Peter B.,Lin Cheng Ting^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,Emergency Medicine

Link

https://link.springer.com/content/pdf/10.1007/s10140-022-02080-y.pdf

Reference15 articles.

1. Fiorentino D, Chung L, Zwerner J, Rosen A, Casciola-Rosen L (2010) The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): a retrospective study. J Am Acad Dermatol 65(1):25–34

2. Huang Y, Mao M (2019) Rapidly progressive interstitial lung disease originating from clinically amyopathic dermatomyositis associated with positive anti-MDA 5 antibody: a case report and literature review. SN Compr Clin Med 1:915–920

3. Nombel A, Fabien N, Coutant F (2021) Dermatomyositis with anti-MDA5 antibodies: bioclinical features, pathogenesis and emerging therapies. Frontiers in immunology 12:773352

4. Tsuji H, Nakashima R, Hosono Y, Imura Y, Yagita M, Yoshifuji H et al (2020) Multicenter prospective study of the efficacy and safety of combined immunosuppressive therapy with high‐dose glucocorticoid, tacrolimus, and cyclophosphamide in interstitial lung diseases accompanied by anti–melanoma differentiation–associated gene 5–positive dermatomyositis. Arthritis & rheumatology (Hoboken, N.J) 72(3):488–98

5. Hall JC, Casciola-Rosen L, Samedy L, Werner J, Owoyemi K, Danoff SK et al (2010) Anti–melanoma differentiation–associated protein 5–associated dermatomyositis: expanding the clinical spectrum. Arthritis care & research. 65(8):1307–15

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The treatment of interstitial lung disease (ILD) in the context of autoimmune diseases: Rheumatoid arthritis and idiopathic inflammatory myositis;Revista Colombiana de Reumatología (English Edition);2024-04

2. Clinical nomogram assisting in discrimination of juvenile dermatomyositis-associated interstitial lung disease;Respiratory Research;2023-11-16

3. The treatment of interstitial lung disease (ILD) in the context of autoimmune diseases: Rheumatoid arthritis and idiopathic inflammatory myositis;Revista Colombiana de Reumatología;2023-11

4. Update on autoantibodies and related biomarkers in autoimmune inflammatory myopathies;Current Opinion in Rheumatology;2023-07-27

5. Immune globulin/methylprednisolone/tacrolimus;Reactions Weekly;2022-12-17